Should You Forget Palantir and Buy These 2 Tech Stocks Instead?

Palantir's U.S. commercial revenue surged 137% to $507M and U.S. government revenue rose 66% to $570M, but the stock trades at a steep forward P/S of 51.5x and forward P/E of 118x, making it expensive at current levels. ServiceNow (forward P/S 8, forward P/E 30) reported subscription revenue up 21% last quarter and its Now Assist AI suite is at $600M ACV, on pace to exceed $1B by year-end, positioning it as a sticky orchestration platform for agentic AI. Salesforce (forward P/S <4, forward P/E 15) shows AgentForce ARR up 169% to $800M, low-double-digit revenue growth and >10% projected CAGR through FY2030, offering a stronger growth-at-reasonable-price profile versus Palantir.

Analysis

Palantir’s narrative is priced like an AI monopoly — that creates asymmetric risk where small execution slippage or slower-than-expected enterprise rollouts will produce outsized downside. The real competitive lever isn’t just model access but durable data ownership and workflow integration; vendors that own permissions, audit trails and MDM layers will capture the margin pool of AI projects and become natural choke points for customers and cloud spend.

Second-order winners are not just other application platforms but the glue: master-data vendors, orchestration/control-plane tools, and cloud networking stacks that reduce latency for model inference. Conversely, point-solution consultancies and one-off model vendors are at risk as customers consolidate to platforms that minimize integration and governance costs.

Key catalysts and risks map to calendar events: near-term (weeks–months) contract renewals and quarterly guidance will move sentiment sharply; medium-term (12–36 months) the test is repeatability — ARR-style predictability and margin expansion. Tail risks include regulatory constraints on cross-domain data use, a customer backlash against perceived vendor lock-in, and broad multiple compression should macro liquidity tighten.

A contrarian read: the market may be underestimating how quickly MDM + orchestration vendors can convert bespoke AI projects into high-margin, predictable offerings — that pathway would compress premium valuations for pure-play AI integrators. Conversely, if a pure-play manages to translate its ontology into a low-cost, highly automatable product, current skepticism could flip rapidly, so monitor signs of true SaaS-like unit economics (net retention, gross margins, multi-year ACV cadence).

Key Decisions for Investors

• Pair trade (3–9 months): short PLTR and long NOW in a 1:1 dollar-weighted ratio. R/R: target 30–45% downside on PLTR vs 15–30% upside on NOW; set a stop if the pair moves against you by 15% to limit asymmetric losses. Hedge with 3–6 month PLTR calls if volatility spikes.
• Hedge/beta-reduction (0–6 months): buy 3–6 month PLTR puts ~10–15% OTM sized to offset 25–35% of your portfolio’s AI exposure. R/R: limited premium loss if thesis fails; payoff meaningful if a valuation shock or large guidance miss occurs.
• Idiosyncratic long (12–24 months): buy INFA (or core MDM/orchestration providers) on pullbacks. R/R: aim for 40–80% upside if MDM becomes a gating factor for enterprise AI, with a downside of ~30% should execution stall — position size 2–3% of equity risk budget.
• Option-defined long (9–18 months): buy a CRM call spread (buy nearer-term ATM call, sell higher strike 9–12 months out) to capture re-rating into agentic AI frameworks. R/R: capped upside ~2–3x premium, limited loss to premium paid; exit if adoption metrics (ARR growth from agentic products) miss by >20% versus consensus.